Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter - Cyclacel Pharmaceuticals ( NASDAQ:CYCCP ) , Cyclacel Pharmaceuticals ( NASDAQ:CYCC )

2 weeks ago

BERKELEY HEIGHTS, N.J., Sept. 03, 2024 ( GLOBE NEWSWIRE ) -- Cyclacel Pharmaceuticals, Inc.

Ticker	Sentiment	Impact
CYCC	Neutral	24 %